Register for Upcoming Webinar on DEC. 8 @ 11AM
2026 China NMPA Bluebook is here:
Monthly NMPA (CFDA) News Roundup covers government announcement, policies, standards, guidelines, QA/recall/AE, and new approvals in medical device and IVD in China. It is edited by China Med Device, LLC
Monthly CFDA News Roundup covers government announcement, policies, standards, guidelines, QA/recall/AE, and new approvals in medical device and IVD in China. It is edited by China Med Device, LLC (www.ChinaMedDevice.com),
The Ministry of Science and Technology of China imposed penalties today (Oct 24th) on 6 companies for violating regulations on human genetic resources. AstraZeneca and 5 domestic companies are on
In the month of September, unprecedented number of medical device guidelines and industry standards issued by CFDA to expedite your registration and renewal. Guideline CFDA issued 12 Technical Review Guidelines
For the first time in 2018, NMPA (formerly CFDA) issued clinical trial incompliant companies report. In this Medical Device Clinical Audit Notice on September 12th, Siemens and Medtronic, along with
Thanks for taking the time to visit China Med Device at the RAPS Convergence in Vancouver. I appreciate the opportunity to share some of the latest developments at NMPA (CFDA)
The price of high-value medical consumables is relatively high. These consumables are usually used for special treatments like cardiac intervention therapy, peripheral vascular intervention, artificial joints replacement, and other organ
NPMA (formerly CFDA) published the “Clinical Exemption Catalog for Medical Devices” yesterday (Sep 30th), in which a total of 855 medical devices and 393 IVDs exempted from clinical trial. It
Visit China Med Device at RAPS October 1 – 4th in Vancouver and Get the Latest Update on NMPA (formerly CFDA) and a Glamor Shot! China Med Device, LLC is
NORTH ANDOVER, Mass. – July 27, 2018 – China Med Device, LLC (CMD), a leader in helping medical technology companies enter the Chinese marketplace, received the contract to guide China
Disease Risk Management A hot application scenario of medical artificial intelligence is disease risk management. When applies to a specific disease treatment area, AI can improve the diagnosis accuracy and
At present, artificial intelligence technology is increasingly mature and permeates all walks of life, among which the deep collection of artificial intelligence and medical treatment has brought new changes to